It’s raining cash in Rain City: More than $140M invested in Seattle startups in 30 days

Is the lack of venture capital funding a problem for the Seattle startup ecosystem?

It’s shaping up to be a very good holiday season for Seattle area startups. At a time when many are preparing to carve the turkey, several Seattle area companies have stuffed their bellies with substantial rounds of cash. Consider this: In the past 30 days, $142 million has flowed into Seattle area companies by GeekWire’s… Read More…

Online wellness startup Limeade squeezes $5M round out of TVC

limeade

Limeade has pulled in $5 million in fresh capital from TVC Capital, money that the six-year-old Bellevue company will use to more than double its staff of 35 people in the coming year. Led by former Intuit marketing vet Henry Albrecht, Limeade develops online corporate wellness programs designed to maker employees healthier and happier. Employers pay a… Read More…

Limeade lands deal with Swedish hospital for wellness program

limeade22

Seattle startup Limeade announced today that it will bring its online corporate wellness program to Swedish hospital, continuing a string of new deals for the company. Swedish is the largest non-profit health provider in the Greater Seattle area, with more than 11,000 employees. “As a leader in the healthcare industry and a pillar in the Seattle community,… Read More…

Tech Moves: Vernon out at Zulily; Microsoft hires FTC attorney who slammed Google; and more

zulily1

Less than a year after arriving at fast-growing Seattle daily deal startup Zulily, chief financial officer Michael Vernon has left the company, GeekWire has learned. Zulily CEO Darrell Cavens confirmed the news, but declined to discuss the specifics around the departure. Vernon joined Zulily last May from Big Fish Games, and at the time of… Read More…

Tech Moves: Dendreon taps new CEO; Anthony Bay lands at Amazon; Globys; Limeade; Allyis; and much more

Mitchell Gold

Dendreon CEO Mitchell Gold is handing over the reins of the Seattle biotechnology company to board member and former Savient Pharmaceuticals CEO John Johnson. Shares of Dendreon, which have falling 58 percent in the past year, gained more than six percent on the news. Gold, who has served as CEO since 2003, plans to serve… Read More…